{
    "2018-07-02": [
        [
            {
                "time": "2018-11-02",
                "original_text": "Novartis Injects Itself Into Planned Rollout of EpiPen Competitor",
                "features": {
                    "keywords": [
                        "Novartis",
                        "EpiPen",
                        "competitor",
                        "rollout"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "Novartis to Spin-Off Alcon as Separate Trading Company",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Alcon",
                        "spin-off",
                        "trading"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-02",
                "original_text": "ADMP Abuzz, MESO Has A Blast, COOL Rebounds, BLFS Up Nearly 150% YTD",
                "features": {
                    "keywords": [
                        "ADMP",
                        "MESO",
                        "COOL",
                        "BLFS",
                        "YTD"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-02",
                "original_text": "Health Care Sector Update for 07/02/2018: ABBV,PRGO,TEVA,NVS,ADMP,MRK,AZN",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector",
                        "Update",
                        "ABBV",
                        "PRGO",
                        "TEVA",
                        "NVS",
                        "ADMP",
                        "MRK",
                        "AZN"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "Novartis Securities Investment Ltd -- Moody's downgrades Novartis' rating to A1; stable outlook",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Moody's",
                        "downgrades",
                        "rating",
                        "A1",
                        "stable",
                        "outlook"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "Adamis Pharma Shares Soar on Deal With Novartis for Epipen Competitor",
                "features": {
                    "keywords": [
                        "Adamis",
                        "Pharma",
                        "Shares",
                        "Soar",
                        "Deal",
                        "Novartis",
                        "Epipen",
                        "Competitor"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "Nordstrom may have trouble, Novartis signs distribution deal, Netflix buys LA billboards",
                "features": {
                    "keywords": [
                        "Nordstrom",
                        "Novartis",
                        "distribution",
                        "deal",
                        "Netflix",
                        "LA",
                        "billboards"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "retail",
                        "healthcare",
                        "media"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "Gilead's (GILD) CAR T Therapy Gets Positive CHMP Opinion",
                "features": {
                    "keywords": [
                        "Gilead",
                        "CAR",
                        "T",
                        "Therapy",
                        "CHMP",
                        "Opinion"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "After a year-long search, Adamis has a partner to market its EpiPen competitor",
                "features": {
                    "keywords": [
                        "Adamis",
                        "EpiPen",
                        "competitor",
                        "partner",
                        "market"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "Nordstrom may have trouble according to analyst, Novartis signs distribution deal for EpiPen competitor, Netflix reportedly buys LA billboards",
                "features": {
                    "keywords": [
                        "Nordstrom",
                        "analyst",
                        "Novartis",
                        "distribution",
                        "deal",
                        "EpiPen",
                        "competitor",
                        "Netflix",
                        "LA",
                        "billboards"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "retail",
                        "healthcare",
                        "media"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "The Swiss Stock Market Pulled Back On Trade War Concerns",
                "features": {
                    "keywords": [
                        "Swiss",
                        "Stock",
                        "Market",
                        "Pulled",
                        "Back",
                        "Trade",
                        "War",
                        "Concerns"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}